When sourcing research-grade compounds for laboratory studies, completing a MOTS-c peptide buy requires verifying analytical purity, lot-specific documentation, and supply chain integrity. MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid mitochondrial-derived peptide investigated for metabolic regulation, cellular stress responses, and exercise-capacity mechanisms in preclinical models.
When sourcing research-grade compounds for laboratory studies, completing a MOTS-c peptide buy requires verifying analytical purity, lot-specific documentation, and supply chain integrity. MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid mitochondrial-derived peptide investigated for metabolic regulation, cellular stress responses, and exercise-capacity mechanisms in preclinical models.
Principal investigators executing a mots-c peptide buy require absolute clarity regarding molecular identity, purity thresholds, and sequence fidelity. MOTS-c is a short mitochondrial-derived peptide (MDP) consisting of 16 amino acids (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg). Because mitochondrial peptides exert potent autocrine, paracrine, and endocrine-like signaling effects in cell culture and animal models, subtle synthesis impurities or truncated sequence contaminants can skew binding assays, metabolic flux measurements, and gene expression profiling.
To ensure reproducible data across multi-phase experimental designs, research laboratories must source compounds manufactured under strict quality systems. Selecting high-purity research peptides verified via reverse-phase high-performance liquid chromatography (RP-HPLC) and electrospray ionization mass spectrometry (ESI-MS) eliminates background noise caused by synthesis byproducts, protecting the integrity of metabolic homeostasis research.
Unlike classic nuclear-encoded signaling peptides, MOTS-c is encoded within the mitochondrial genome—specifically within the 12S ribosomal RNA (rRNA) gene locus. Discovered through bioinformatic screening of small open reading frames (sORFs), MOTS-c represents a distinct paradigm in retro-grade cellular communication, wherein the mitochondrion releases signaling factors to alter nuclear gene transcription.
In vitro data indicate that under conditions of metabolic stress or nutrient deprivation, MOTS-c translocates from the cytoplasm to the cell nucleus. Once inside the nucleus, it interacts directly with transcription factors such as NRF2 (nuclear factor erythroid 2-related factor 2) and regulates adaptive stress-response pathways. Preclinical models demonstrate that this retrograde signaling system plays a foundational role in maintaining cellular energy balance, mitochondrial biogenesis, and systemic metabolic flexibility.
The primary biochemical cascade associated with MOTS-c activity centers on the activation of 5'-AMP-activated protein kinase (AMPK), the master regulator of cellular energy status. In rodent models of metabolic dysregulation, administration of MOTS-c has been observed to stimulate AMPK phosphorylation without increasing intracellular AMP/ATP ratios directly. Instead, preclinical studies suggest that MOTS-c inhibits the folate cycle, leading to an accumulation of the intermediate 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), a natural agonist of AMPK.
Activation of the MOTS-c/AICAR/AMPK axis subsequently promotes downstream physiological processes in laboratory models, including enhanced glucose uptake in skeletal muscle cells via GLUT4 translocation, accelerated fatty acid oxidation, and improved systemic insulin sensitivity. Research published in murine paradigms demonstrates that target tissue response is highly dependent on compound purity, highlighting why validated sourcing during a mots-c peptide buy is essential for consistent mechanistic outcomes.
Furthermore, in vitro assays using primary myoblasts indicate that MOTS-c treatment preserves mitochondrial membrane potential and reduces ROS (reactive oxygen species) generation during acute nutrient overload. These findings position MOTS-c as a key reference standard in studies exploring metabolic endurance, cellular longevity, and mitochondrial quality control mechanisms.
Mitochondrial research frequently evaluates multiple peptide classes to discern distinct pathways of organelle support and metabolic modulation. Three prominent compounds in this field include MOTS-c, SS-31 (Elamipretide), and Humanin. While all three peptides interface with mitochondrial biology, their structural profiles and primary mechanisms of action diverge significantly.
MOTS-c functions primarily as a nuclear translocating regulator of metabolic gene expression and AMPK signaling. In contrast, SS-31 is a synthetic tetrapeptide designed to selectively target the inner mitochondrial membrane where it binds cardiolipin, optimizing electron transport chain efficiency and quenching ROS directly at the source. Meanwhile, Humanin—another 24-amino acid mitochondrial-derived peptide encoded in the 16S rRNA gene—exerts neuroprotective and anti-apoptotic effects by modulating Bax translocation and insulin-like growth factor binding protein-3 (IGFBP-3). Researchers designing comparative protocols often source these compounds together through our catalog of mitochondrial peptides to evaluate synergistic mechanisms in metabolic and longevity assays.
A major area of ongoing investigation involves the role of MOTS-c in exercise mimetic pathways. Preclinical rodent studies demonstrate that acute and chronic administration of MOTS-c enhances physical performance, running capacity, and skeletal muscle adaptation in both young and aged mice. These functional changes correlate with upregulated expression of genes involved in oxidative phosphorylation and heat shock response pathways.
In vitro models of physiological stress—such as heat shock, oxidative challenge, or glucose deprivation—reveal that cells treated with MOTS-c display enhanced survival rates and superior metabolic plasticity. Researchers measuring oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) via extracellular flux analysis regularly employ MOTS-c to probe the boundaries of mitochondrial adaptation under variable metabolic loads.
Proper handling and storage protocols are vital to preserving the structural integrity of MOTS-c throughout an experimental timeline. Lyophilized MOTS-c peptide should be stored at -20°C or -80°C upon receipt to prevent hydrolytic or oxidative degradation. Protect the product from light exposure and minimize thermal fluctuations during storage.
For reconstitution, use sterile, laboratory-grade solvents such as bacteriostatic water, sterile water for injection, or phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of your cell culture or animal model assays. When dissolving the lyophilized cake, allow the vial to equilibrate to room temperature before adding the solvent. Gently swirl or invert the container; vigorous vortexing or high-shear agitation must be avoided, as it can induce peptide aggregation or structural denaturation.
Once reconstituted, working aliquots should be prepared immediately to avoid repeated freeze-thaw cycles, which cause progressive loss of bioactivity. Reconstituted liquid aliquots stored at -20°C remain stable for short-term experimental blocks, while long-term stability requires storage at -80°C in low-protein-binding microcentrifuge tubes.
When placing a order for a mots-c peptide buy, receiving robust, lot-specific analytical verification is non-negotiable. Every production batch must be accompanied by a comprehensive Certificate of Analysis (COA) generated by an independent, accredited laboratory.
Key metrics on a PX1 Research COA include RP-HPLC purity reports demonstrating single peak dominance (typically ≥98% purity), ESI-MS mass spec spectrum verifying exact molecular weight (1874.2 Da for MOTS-c), and quantitative endotoxin testing. Evaluating mass spectra confirms the absence of deletion sequences, truncated peptides, or residual protecting groups from solid-phase peptide synthesis (SPPS).
In immunological, cardiovascular, and cell-culture research, lipopolysaccharide (LPS) or endotoxin contamination poses a severe threat to experimental validity. Endotoxins trigger toll-like receptor 4 (TLR4) cascades, inducing non-specific inflammatory responses that confound gene expression data, cytokine assays, and metabolic measurements.
PX1 Research enforces strict endotoxin screening via Chromogenic Limulus Amebocyte Lysate (LAL) testing on every peptide lot. By ensuring endotoxin thresholds fall well below standard laboratory limits (<0.01 EU/mg), investigators can confidently attribute observed cellular responses directly to MOTS-c signaling rather than bacterial contamination.
PX1 Research operates as a trusted USA-based supplier dedicated exclusively to laboratory researchers, academic institutions, and biotechnology organizations. All products are synthesized in state-of-the-art, GMP-compliant facilities and undergo independent verification in ISO 17025-accredited testing laboratories.
By maintaining domestic inventory dispatched directly from our California and Arizona logistics hubs, PX1 eliminates international customs delays and cold-chain exposure. Academic and corporate accounts seeking bulk procurement for large-scale preclinical trials can access custom lot reservation and volume pricing via our bulk wholesale lab accounts.
What analytical methods confirm the identity and purity of MOTS-c?
PX1 Research verifies MOTS-c identity and purity using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for chromatographic purity (≥98%) and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm exact molecular weight (1874.2 Da).
How should lyophilized MOTS-c be stored upon arrival?
Lyophilized MOTS-c should be stored at -20°C or -80°C in a desiccated environment protected from light. Under these conditions, the powder remains stable for up to 24 months.
What solvent is recommended for reconstituting MOTS-c for cell culture assays?
MOTS-c can be reconstituted in sterile bacteriostatic water, sterile water for injection, or sterile PBS (pH 7.4). Avoid high-shear mixing or vortexing during solubilization.
How does MOTS-c differ from SS-31 in mechanism?
MOTS-c is a 16-amino acid nuclear-translocating peptide that activates AMPK and regulates metabolic gene transcription. SS-31 is a tetrapeptide that directly targets inner mitochondrial cardiolipin to reduce ROS generation and optimize electron transport.
What are the endotoxin limits for PX1 Research MOTS-c?
Every lot of MOTS-c undergoes chromogenic LAL testing to ensure endotoxin levels remain below strictly controlled threshold limits (<0.01 EU/mg), preventing non-specific immune responses in cell cultures.
Can reconstituted MOTS-c undergo multiple freeze-thaw cycles?
No. Repeated freeze-thaw cycles degrade peptide structural integrity. Reconstituted MOTS-c should be divided into single-use laboratory working aliquots and stored at -20°C or -80°C.
Is MOTS-c supplied by PX1 Research intended for human therapeutic use?
No. All MOTS-c products provided by PX1 Research are strictly for laboratory research, in vitro assays, and preclinical animal models. They are not intended for human or veterinary use.
Where does PX1 Research ship MOTS-c orders from?
Orders ship domestically from PX1 distribution centers located in California and Arizona, offering same-day shipping on orders placed Monday through Friday before cut-off times.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.